Munindra Ruwali

616 total citations
22 papers, 416 citations indexed

About

Munindra Ruwali is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Munindra Ruwali has authored 22 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Munindra Ruwali's work include Glutathione Transferases and Polymorphisms (9 papers), Genomics, phytochemicals, and oxidative stress (8 papers) and Lung Cancer Treatments and Mutations (4 papers). Munindra Ruwali is often cited by papers focused on Glutathione Transferases and Polymorphisms (9 papers), Genomics, phytochemicals, and oxidative stress (8 papers) and Lung Cancer Treatments and Mutations (4 papers). Munindra Ruwali collaborates with scholars based in India, United States and Czechia. Munindra Ruwali's co-authors include Devendra Parmar, Mohan C. Pant, Parag P. Shah, Neeraj Mathur, Arvind Pratap Singh, Madhu Singh, Anwar Jamal Khan, Sunishtha S. Yadav, Ram Lakhan Singh and Zeeshan Fatima and has published in prestigious journals such as Journal of Applied Microbiology, Frontiers in Pharmacology and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

In The Last Decade

Munindra Ruwali

22 papers receiving 402 citations

Peers

Munindra Ruwali
Dan Olson United States
Sushma Thomas United States
Munindra Ruwali
Citations per year, relative to Munindra Ruwali Munindra Ruwali (= 1×) peers Jiayan Huang

Countries citing papers authored by Munindra Ruwali

Since Specialization
Citations

This map shows the geographic impact of Munindra Ruwali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Munindra Ruwali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Munindra Ruwali more than expected).

Fields of papers citing papers by Munindra Ruwali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Munindra Ruwali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Munindra Ruwali. The network helps show where Munindra Ruwali may publish in the future.

Co-authorship network of co-authors of Munindra Ruwali

This figure shows the co-authorship network connecting the top 25 collaborators of Munindra Ruwali. A scholar is included among the top collaborators of Munindra Ruwali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Munindra Ruwali. Munindra Ruwali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Priya, et al.. (2024). Clinical relevance of long non-coding RNA in acute myeloid leukemia: A systematic review with meta-analysis. Leukemia Research. 147. 107595–107595. 3 indexed citations
2.
Pandey, Amit Kumar, et al.. (2023). Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges. Frontiers in Pharmacology. 14. 1244597–1244597. 14 indexed citations
3.
Handa, Mayank, et al.. (2022). Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer’s disease. Mitochondrion. 64. 112–124. 11 indexed citations
4.
Bumbrah, Gurvinder Singh, et al.. (2022). Diagnostic efficiency of RT-LAMP integrated CRISPR-Cas technique for COVID-19: A systematic review and meta-analysis. Pathogens and Global Health. 116(7). 410–420. 13 indexed citations
5.
Singh, Ajit, Mayank Handa, Munindra Ruwali, et al.. (2021). Nanocarrier mediated autophagy: An emerging trend for cancer therapy. Process Biochemistry. 109. 198–206. 21 indexed citations
6.
Fatima, Zeeshan, et al.. (2021). An Inventory of Diagnostic Tools for Detection of COVID-19. Current Molecular Medicine. 22(7). 608–620. 3 indexed citations
7.
Ruwali, Munindra, Madhu Singh, Rahul Pandey, et al.. (2020). Interaction of glutathione‐s‐transferase genotypes with environmental risk factors in determining susceptibility to head and neck cancer and treatment response and survival outcome. Environmental and Molecular Mutagenesis. 61(5). 574–584. 12 indexed citations
8.
Ruwali, Munindra. (2017). Role of Genetic Variations in Determining Treatment Outcome in Head and Neck Cancer. European Medical Journal. 114–121. 1 indexed citations
9.
Ruwali, Munindra, et al.. (2016). Clinical Management of Head and Neck Cancer Cases: Role of Pharmacogenetics of CYP2 and GSTs. Oncology Research and Treatment. 39(4). 221–226. 7 indexed citations
10.
Ruwali, Munindra, et al.. (2016). Association of genetic variability in enzymes metabolizing chemotherapeutic agents with treatment response in head and neck cancer cases. Asia-Pacific Journal of Clinical Oncology. 13(2). e11–e20. 7 indexed citations
11.
Ruwali, Munindra, Madhu Singh, Mohan C. Pant, & Devendra Parmar. (2011). Polymorphism in glutathione S-transferases: Susceptibility and treatment outcome for head and neck cancer. Xenobiotica. 41(12). 1122–1130. 27 indexed citations
12.
Singh, Arvind Pratap, Mohan C. Pant, Munindra Ruwali, et al.. (2011). Polymorphism in cytochrome P450 1A2 and their interaction with risk factors in determining risk of squamous cell lung carcinoma in men. Cancer Biomarkers. 8(6). 351–359. 23 indexed citations
13.
Ruwali, Munindra & Devendra Parmar. (2010). Association of functionally important polymorphisms in cytochrome P450s with squamous cell carcinoma of head and neck.. PubMed. 48(7). 651–65. 11 indexed citations
14.
Khan, Anwar Jamal, Munindra Ruwali, Gourdas Choudhuri, et al.. (2009). Polymorphism in cytochrome P450 2E1 and interaction with other genetic risk factors and susceptibility to alcoholic liver cirrhosis. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 664(1-2). 55–63. 24 indexed citations
15.
Ruwali, Munindra, Mohan C. Pant, Parag P. Shah, Bhartendu Nath Mishra, & Devendra Parmar. (2009). Polymorphism in cytochrome P450 2A6 and glutathione S-transferase P1 modifies head and neck cancer risk and treatment outcome. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 669(1-2). 36–41. 26 indexed citations
16.
Singh, Arvind Pratap, Parag P. Shah, Munindra Ruwali, et al.. (2009). Polymorphism in Cytochrome P4501A1 is Significantly Associated with Head and Neck Cancer Risk. Cancer Investigation. 27(8). 869–876. 30 indexed citations
17.
Ruwali, Munindra, Anwar Jamal Khan, Parag P. Shah, et al.. (2009). Cytochrome P450 2E1 and head and neck cancer: Interaction with genetic and environmental risk factors. Environmental and Molecular Mutagenesis. 50(6). 473–482. 33 indexed citations
18.
Yadav, Sunishtha S., Munindra Ruwali, Mohan C. Pant, et al.. (2009). Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 684(1-2). 49–55. 23 indexed citations
19.
Yadav, Sunishtha S., Munindra Ruwali, Parag P. Shah, et al.. (2008). Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 644(1-2). 31–37. 23 indexed citations
20.
Singh, Madhu, Parag P. Shah, Arvind Pratap Singh, et al.. (2007). Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 638(1-2). 184–194. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026